Tatyana R. Tsareva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tatyana R. Tsareva has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Evgeniy V. Sorokin
ФГБУ «Научно-исследовательский институт гриппа им. А.А. Смородинцева» Минздрава России
2 shared publications - Alexsander V. Lyashko
Gamaleya National Research Center for Epidemiology and Microbiology
1 shared publication - Anna A. Sominina
Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation
1 shared publication - Boris I. Timofeev
National Research Center for Epidemiology and Microbiology named after honorary academician N.F. Gamaleya
1 shared publication - Darya Mikhaylovna Danilenko
Smorodintsev Research Institute of Influenza, 197022 Saint Petersburg, Russia
1 shared publication - E. K. Artemov
Институт вирусологии им. Д.И. Ивановского ФГБУ «Национальный исследовательский центр эпидемиологии и микробиологии имени почётного академика Н.Ф. Гамалеи» Минздрава России
1 shared publication
Latest Publications
- Open Access
- 30 June 2026
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 71 (3) , 272-283
Characterization of neutralizing epitopes of the respiratory syncytial virus (Pneumoviridae: Orthopneumovirus: Orthopneumovirus hominis) F protein using a panel of monoclonal antibodies and escape mutants
The aim of this work was to identify neutralizing epitopes of the F protein of respiratory syncytial virus subtype A (RSV-A) using a panel of monoclonal antibodies (mAbs) with characterized epitope targeting. Materials and methods. Neutralizing activity was assessed using a microcultural ELISA. Results. All studied MAbs neutralized the original virus, albeit less potently than palivizumab. Escape mutants (EMs) resistant to neutralization by the corresponding homologous antibody were generated by passaging the virus in the presence of each mAb. For five mAbs (5H8, 7H8, 9E12, 12C9, 5F8), the loss of neutralizing activity was accompanied by a sharp reduction in binding to the EMs (negative selection), whereas for three others (5F3, 7B12, 10G6), binding was largely preserved, indicating conformational changes critical for neutralization function but not for binding to the F protein itself (positive selection). Whole-genome sequencing revealed multiple substitutions in the EMs affecting not only the F protein (N276S in antigenic site II and R190S in site V) but also other viral proteins (G, L, N, P, M, M2-2). Conclusion. Based on competitive ELISA data and sequencing results, we propose the identification of two spatially adjacent neutralizing antigenic sites (A and B) on the F protein.
- 30 June 2026
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 71 (3) , 272-283
Open AccessCharacterization of neutralizing epitopes of the respiratory syncytial virus (Pneumoviridae: Orthopneumovirus: Orthopneumovirus hominis) F protein using a panel of monoclonal antibodies and escape mutants
The aim of this work was to identify neutralizing epitopes of the F protein of respiratory syncytial virus subtype A (RSV-A) using a panel of monoclonal antibodies (mAbs) with characterized epitope targeting. Materials and methods. Neutralizing activity was assessed using a microcultural ELISA. Results. All studied MAbs neutralized the original virus, albeit less potently than palivizumab. Escape mutants (EMs) resistant to neutralization by the corresponding homologous antibody were generated by passaging the virus in the presence of each mAb. For five mAbs (5H8, 7H8, 9E12, 12C9, 5F8), the loss of neutralizing activity was accompanied by a sharp reduction in binding to the EMs (negative selection), whereas for three others (5F3, 7B12, 10G6), binding was largely preserved, indicating conformational changes critical for neutralization function but not for binding to the F protein itself (positive selection). Whole-genome sequencing revealed multiple substitutions in the EMs affecting not only the F protein (N276S in antigenic site II and R190S in site V) but also other viral proteins (G, L, N, P, M, M2-2). Conclusion. Based on competitive ELISA data and sequencing results, we propose the identification of two spatially adjacent neutralizing antigenic sites (A and B) on the F protein.
- Open Access
- 9 July 2021
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 66 (3) , 189-197
Monoclonal antibodies to hemagglutinin of influenza A/H7N3 virus (Orthomyxoviridae: Alphainfluenzavirus: Influenza A virus)
Introduction. Variants of influenza virus A/H7 have the same high pandemic potential as A/H5. However, the information about the antigenic structure of H7 hemagglutinin (НА) is considerably inferior in quantitative terms to similar data for H5 НА.The aims of the study were development and characterization of the monoclonal antibodies (MAbs) panel for HA subtype H7 of the influenza A virus.Material and methods. Viruses were accumulated in 10-day-old chicken embryos. Purification and concentration of the virus, determination of protein concentration, preparation of MAbs and ascitic fluids, hemagglutination and hemagglutination inhibition (HI) tests, assessment of antibodies’ activity in indirect enzyme-linked immunosorbent assay (ELISA), as well as determination of MAbs isotypes and neutralization reaction (NR) were carried out by standard methods.Results. The obtained MAbs to А/mallard/Netherlands/12/2000 (H7N3) strain were studied in HI test with a set of strains of different years of isolation belonging to different evolutionary groups. MAbs had a reduced reactivity compared to the immunogen-virus for all the studied strains. Cross-interaction of MAbs 9E11 and 9G12 in HI test with influenza A/H15 virus has been observed.Discussion. Influenza A agent with H7 HA variant could serve as a potential cause of a future pandemic. Development of the MAbs panel for subtype H7 HA is an urgent task for both veterinary medicine and public health.Conclusion. The obtained MAbs can be used not only for epitope mapping of the H7 HA molecule (currently insufficiently studied) and as reagents for diagnostic assays, but also for determining common («universal») epitopes in HA of different strains of this subtype.
- 9 July 2021
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 66 (3) , 189-197
Open AccessMonoclonal antibodies to hemagglutinin of influenza A/H7N3 virus (Orthomyxoviridae: Alphainfluenzavirus: Influenza A virus)
Introduction. Variants of influenza virus A/H7 have the same high pandemic potential as A/H5. However, the information about the antigenic structure of H7 hemagglutinin (НА) is considerably inferior in quantitative terms to similar data for H5 НА.The aims of the study were development and characterization of the monoclonal antibodies (MAbs) panel for HA subtype H7 of the influenza A virus.Material and methods. Viruses were accumulated in 10-day-old chicken embryos. Purification and concentration of the virus, determination of protein concentration, preparation of MAbs and ascitic fluids, hemagglutination and hemagglutination inhibition (HI) tests, assessment of antibodies’ activity in indirect enzyme-linked immunosorbent assay (ELISA), as well as determination of MAbs isotypes and neutralization reaction (NR) were carried out by standard methods.Results. The obtained MAbs to А/mallard/Netherlands/12/2000 (H7N3) strain were studied in HI test with a set of strains of different years of isolation belonging to different evolutionary groups. MAbs had a reduced reactivity compared to the immunogen-virus for all the studied strains. Cross-interaction of MAbs 9E11 and 9G12 in HI test with influenza A/H15 virus has been observed.Discussion. Influenza A agent with H7 HA variant could serve as a potential cause of a future pandemic. Development of the MAbs panel for subtype H7 HA is an urgent task for both veterinary medicine and public health.Conclusion. The obtained MAbs can be used not only for epitope mapping of the H7 HA molecule (currently insufficiently studied) and as reagents for diagnostic assays, but also for determining common («universal») epitopes in HA of different strains of this subtype.